Charles Bennett to Risk
This is a "connection" page, showing publications Charles Bennett has written about Risk.
Connection Strength
0.300
-
Selection of contraceptive therapy for patients with thrombophilia: a review of the evidence. J Womens Health (Larchmt). 2014 Apr; 23(4):318-26.
Score: 0.100
-
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA. 2008 Feb 27; 299(8):914-24.
Score: 0.066
-
Ticlopidine and TTP after coronary stenting. JAMA. 1999 Nov 10; 282(18):1717; author reply 1718-9.
Score: 0.037
-
Types of oral contraceptives and breast cancer survival among women enrolled in Medicaid: A competing-risk model. Maturitas. 2017 Jan; 95:42-49.
Score: 0.030
-
Progestin and breast cancer risk: a systematic review. Breast Cancer Res Treat. 2016 Jan; 155(1):3-12.
Score: 0.028
-
Angiotensin receptor blockers and risk of prostate cancer among United States veterans. J Clin Pharmacol. 2013 Jul; 53(7):773-8.
Score: 0.024
-
Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007 May 09; 297(18):1992-2000.
Score: 0.016